Search alternatives:
significant changes » significant challenge (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
linear decrease » linear increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant changes » significant challenge (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
linear decrease » linear increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
Pathophysiological mechanisms linking hyperammonemia to sarcopenia and cerebral changes.
Published 2025Subjects: -
208
-
209
-
210
-
211
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
-
212
GWAS analysis identifies several single nucleotide polymorphisms (SNPs) that are associated with the changes in viral copies.
Published 2024“…(C) The corresponding synonymous (triangles) and non-synonymous (circles) amino acid changes that associate with increased or decreased viral copies. …”
-
213
ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection.
Published 2025Subjects: -
214
-
215
-
216
-
217
-
218
-
219
Results of the LMM analysis for IOP change.
Published 2025“…LMM analysis showed significant coefficients for IOP change in relation to postoperative days and preoperative IOP, and for GMS change in relation to postoperative days, β blockers (BB), and Rho kinase inhibitors (ROCK inhibitors). …”
-
220
Results of the LMM analysis for GMS change.
Published 2025“…LMM analysis showed significant coefficients for IOP change in relation to postoperative days and preoperative IOP, and for GMS change in relation to postoperative days, β blockers (BB), and Rho kinase inhibitors (ROCK inhibitors). …”